Market Place
Sourcing Support
Bridge Biotherapeutics And HitGen Partner On Cancer Therapeutics
22 Aug 2024 //
PR NEWSWIRE
HitGen And Xtalks Host Webinar On DNA-Encoded Library Technology
16 Jul 2024 //
PR NEWSWIRE
SGC and HitGen Announce Research Collaboration
28 Sep 2023 //
PR NEWSWIRE
HitGen launches a newly upgraded version of OpenDEL
26 Jun 2023 //
PR NEWSWIRE
HitGen Announces Drug Discovery Research Agreement with ARase Therapeutics
18 May 2023 //
PR NEWSWIRE
HitGen enters research agreement with Nitrase Therapeutics
13 Dec 2022 //
PHARMABIZ
HitGen inks research collaboration with Daewoong Pharma
15 Nov 2022 //
PHARMABIZ
HitGen and Unison Medicines join hands to develop anti-infectives
06 Sep 2022 //
BIOSPECTRUMASIA
Vernalis Research, a fully owned subsidiary of HitGen Inc., and Unison Medicines
05 Sep 2022 //
PHARMABIZ
"OpenDEL 3.0 - DRUG DISCOVERY PARTNER" webinar offered by HitGen
01 Aug 2022 //
PRNEWSWIRE
HitGen and UPPTHERA Extend PROTAC Research Collaboration
06 Apr 2022 //
PRNEWSWIRE
HitGen Completes 3 year collaboration with MTPC for novel hit compounds
24 Feb 2022 //
PRNEWSWIRE
HitGen taps Cambridge Molecular for `deep learning` work
05 Nov 2021 //
FIERCEBIOTECH
HitGen and Cambridge Molecular announce a strategic partnership
04 Nov 2021 //
BUSINESSWIRE
Gilead bought his last biotech. Now, Helin has a new startup
01 Nov 2021 //
FIERCEBIOTECH
Vernalis and Hannibal Innovation Announce the Creation of Dania Therapeutics ApS
31 Oct 2021 //
BUSINESSWIRE
Cedilla adds $25M to series B to test two cancer drugs in trials
26 Oct 2021 //
FIERCEBIOTECH
Dorian and HitGen Announce Research Collaboration Focused on DNA-Encoded
24 May 2021 //
BUSINESSWIRE
HitGen, UPPTHERA collaborate for drug discovery research
02 Mar 2021 //
BIOSPECTRUMASIA
HitGen, UPPTHERA collaborate for drug discovery research
01 Mar 2021 //
BIOSPECTRUMASIA
HitGen and UPPTHERA Enter Into Drug Discovery Research Collaboration
28 Feb 2021 //
BUSINESSWIRE
HitGen Announces License Agreement With Merck & Co., Inc., Kenilworth, NJ USA
21 Dec 2020 //
BUSINESSWIRE
HitGen Announces License Agreement With Merck & Co., Inc., Kenilworth, NJ USA
21 Dec 2020 //
BUSINESSWIRE
Cedilla and HitGen Announce Research Collaboration Focused on DNA-Encoded
30 Nov 2020 //
BUSINESSWIRE
HitGen Licenses Its Trk/ROS1 Inhibitor HG030 to Baiyunshan for Development
10 Nov 2020 //
BIOSPACE
HitGen to acquire UK-based fragment and structure-based drug discovery research
12 Oct 2020 //
PHARMABIZ
HitGen picks up Vernalis` drug hunters from Ligand for $25M
12 Oct 2020 //
FIERCE BIOTECH
HitGen and Morphic Extend Drug Discovery Research Collaboration
06 Jul 2020 //
BUSINESSWIRE
HitGen pens Evotec R&D anti-infective collab
11 Jun 2020 //
FIERCE BIOTECH
HitGen and Evotec SE Enter Into Drug Discovery Research Collaboration
09 Jun 2020 //
BUSINESSWIRE
Oncodesign and HitGen Enter Strategic Partnership
28 May 2020 //
CONTRACTPHARMA
HitGen inks agreement with Mitsubishi Tanabe
08 Apr 2020 //
BIOSPECTRUMASIA
HitGen and MTPC Enter Into License Agreement
07 Apr 2020 //
BUSINESSWIRE
HitGen and BioAge Announce Research Progress in DNA-Encoded Library Based Drug
05 Apr 2020 //
BUSINESSWIRE
HitGen and Kaken Enter Into License Agreement
10 Mar 2020 //
BUSINESS WIRE
HitGen to develop novel class of drugs with MTPC
18 Dec 2019 //
BIOSPECTRUMASIA
HitGen with Janssen to build novel DNA-Encoded Libraries
10 Dec 2019 //
BIOSPECTRUMASIA
LEO Pharma, HitGen to develop novel class of derma drugs
12 Nov 2019 //
BIOSPECTRUMASIA
HitGen Enters into DNA-Encoded Library Based Drug Discovery Research
16 Oct 2019 //
BUSINESSWIRE
HitGen, Kaken Pharma ink agreement to develop novel class of drugs
15 Apr 2019 //
PHARMABIZ
HitGen and Kaken Enter Into License Agreement
10 Apr 2019 //
BUSINESSWIRE
HitGen & Almirall Enter DNA-Encoded Library Based Innovative Drug Discovery
25 Mar 2019 //
BUSINESSWIRE
HitGen & SPARC Enter DNA-Encoded Library Based Drug Discovery Collaboration
13 Mar 2019 //
BUSINESSWIRE
Sun Pharma Advanced gains 3% on research collaboration with Chinese firm
12 Mar 2019 //
MONEYCONTROL
